These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 17024114

  • 1. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.
    Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P, Sica S, Leone G, Efremov DG.
    Leukemia; 2007 Jan; 21(1):110-20. PubMed ID: 17024114
    [Abstract] [Full Text] [Related]

  • 2. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C, López-Giral S, Alfonso-Pérez M, de Soria VG, Loscertales J, Guasch-Vidal S, Beltrán AE, Zapata JM, Muñoz-Calleja C.
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [Abstract] [Full Text] [Related]

  • 3. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C.
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [Abstract] [Full Text] [Related]

  • 4. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.
    J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
    [Abstract] [Full Text] [Related]

  • 5. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.
    Cuní S, Pérez-Aciego P, Pérez-Chacón G, Vargas JA, Sánchez A, Martín-Saavedra FM, Ballester S, García-Marco J, Jordá J, Durántez A.
    Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625
    [Abstract] [Full Text] [Related]

  • 6. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
    Tarnani M, Laurenti L, Longo PG, Piccirillo N, Gobessi S, Mannocci A, Marietti S, Sica S, Leone G, Efremov DG.
    Leuk Res; 2010 Sep; 34(9):1189-94. PubMed ID: 20074801
    [Abstract] [Full Text] [Related]

  • 7. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG.
    Blood; 2005 Jun 15; 105(12):4820-7. PubMed ID: 15728130
    [Abstract] [Full Text] [Related]

  • 8. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM, Tonino SH, Elias JA, Jaspers A, Luijks DM, Kater AP, van Lier RA, van Oers MH, Eldering E.
    Oncogene; 2010 Sep 09; 29(36):5071-82. PubMed ID: 20581863
    [Abstract] [Full Text] [Related]

  • 9. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G.
    J Leukoc Biol; 2002 Jul 09; 72(1):83-92. PubMed ID: 12101266
    [Abstract] [Full Text] [Related]

  • 10. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, Chen W.
    Blood; 2010 Jun 17; 115(24):5041-52. PubMed ID: 20339095
    [Abstract] [Full Text] [Related]

  • 11. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
    Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG.
    Blood; 2008 Jan 15; 111(2):846-55. PubMed ID: 17928528
    [Abstract] [Full Text] [Related]

  • 12. Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G, Jadidi-Niaragh F, Hojjat-Farsangi M, Asgarian-Omran H, Yousefi M, Tahmasebi F, Khoshnoodi J, Razavi SM, Saboor-Yaraghi AA, Rabbani H, Jeddi-Tehrani M, Shokri F.
    Cytokine; 2013 Jun 15; 62(3):439-45. PubMed ID: 23579027
    [Abstract] [Full Text] [Related]

  • 13. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L, Gillet N, Stamatopoulos B, Delforge A, Dejeneffe M, Massy M, Meuleman N, Kentos A, Martiat P, Willems L, Bron D.
    Exp Hematol; 2007 Oct 15; 35(10):1527-37. PubMed ID: 17697742
    [Abstract] [Full Text] [Related]

  • 14. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.
    Suljagic M, Laurenti L, Tarnani M, Alam M, Malek SN, Efremov DG.
    Leukemia; 2010 Dec 15; 24(12):2063-71. PubMed ID: 20861921
    [Abstract] [Full Text] [Related]

  • 15. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M, Pantaleoni F, Riganti C, Vitale C, Rigoni M, Peola S, Castella B, Foglietta M, Griggio V, Drandi D, Ladetto M, Bosia A, Boccadoro M, Massaia M.
    Leukemia; 2011 May 15; 25(5):828-37. PubMed ID: 21372840
    [Abstract] [Full Text] [Related]

  • 16. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
    Cahill N, Bergh AC, Kanduri M, Göransson-Kultima H, Mansouri L, Isaksson A, Ryan F, Smedby KE, Juliusson G, Sundström C, Rosén A, Rosenquist R.
    Leukemia; 2013 Jan 15; 27(1):150-8. PubMed ID: 22922567
    [Abstract] [Full Text] [Related]

  • 17. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
    Wang Z, Jiang C, Ganther H, Lü J.
    Cancer Res; 2001 Oct 01; 61(19):7171-8. PubMed ID: 11585751
    [Abstract] [Full Text] [Related]

  • 18. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.
    Deglesne PA, Chevallier N, Letestu R, Baran-Marszak F, Beitar T, Salanoubat C, Sanhes L, Nataf J, Roger C, Varin-Blank N, Ajchenbaum-Cymbalista F.
    Cancer Res; 2006 Jul 15; 66(14):7158-66. PubMed ID: 16849562
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I, Kuliczkowski K.
    Haematologica; 2001 Dec 15; 86(12):1296-304. PubMed ID: 11726322
    [Abstract] [Full Text] [Related]

  • 20. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.
    Secchiero P, Melloni E, Tiribelli M, Gonelli A, Zauli G.
    J Leukoc Biol; 2008 Feb 15; 83(2):434-7. PubMed ID: 17998303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.